α-Ketoamide Whitening Compounds With Improved TYR Binding and Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current whitening products for skin pigmentation disorders, such as melasma and postinflammatory hyperpigmentation, often pose safety risks and have inefficiencies due to poor solubility, susceptibility to degradation, and strong irritability, despite their potential to inhibit tyrosinase activity.
Innovation Solution
Development of α-ketoamide or substituted oxamide ester compounds with specific structural formulas, including alkyl, cycloalkyl, or amine groups, which can inhibit tyrosinase activity and suppress melanin synthesis, formulated as cosmetic or dermatological preparations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If common whitening agents like hydroquinone, arbutin, kojic acid, or rhododenol are used to inhibit tyrosinase activity, then melanin production is reduced, but safety risks increase due to side effects such as exogenous ochronosis, leukoderma, endocrine disruption, or severe irritation
Solution Approach 1:
The patent modifies the chemical structure of resorcinol-based compounds by introducing specific substituents (aminothiazolyl group at position 4, and various alkyl/cycloalkyl groups at positions 1 and 3) to change the physical and chemical parameters of the molecule. This structural modification improves safety by reducing irritability and susceptibility to degradation while maintaining TYR inhibitory activity through the preserved resorcinol core structure
Solution Approach 2:
The patent creates composite molecular structures by combining the resorcinol scaffold with aminothiazolyl and various alkyl/cycloalkyl substituents. This composite approach allows the molecule to integrate multiple functional properties: the resorcinol core provides TYR inhibition, the aminothiazolyl group enhances stability and reduces degradation, and the alkyl/cycloalkyl groups improve solubility and reduce irritability
2Reliability
If resorcinol-based compounds are used to inhibit tyrosinase activity, then melanin production is reduced, but water solubility decreases leading to poor efficacy
Solution Approach 1:
The patent introduces polar aminothiazolyl groups and hydrophilic substituents (such as hydroxymethyl, methoxymethyl, and carboxymethyl groups) into the resorcinol structure. These modifications change the polarity and hydrogen-bonding capabilities of the molecule, significantly improving water solubility while maintaining the planar aromatic structure necessary for TYR inhibition
3Reliability
If resorcinol-based compounds are used to inhibit tyrosinase activity, then melanin production is reduced, but susceptibility to degradation and discoloration increases
Solution Approach 1:
The patent extracts the reactive hydroxyl groups from the resorcinol structure and replaces them with more stable substituents (methoxymethyl, carboxymethyl, aminothiazolyl groups). This extraction of the vulnerable functional groups while retaining the core aromatic system reduces susceptibility to oxidation and degradation, improving compositional stability
Solution Approach 2:
The patent performs preliminary chemical modification of the resorcinol structure by pre-installing protective substituents (such as methoxymethyl and carboxymethyl groups) that prevent subsequent degradation and discoloration. This preliminary protection allows the compound to maintain stability during storage and application
4Reliability
If resorcinol-based compounds are used to inhibit tyrosinase activity, then melanin production is reduced, but unpleasant odors are generated
Solution Approach 1:
The patent modifies the volatility and molecular weight parameters of the resorcinol compound by introducing heavier alkyl and cycloalkyl substituents (isopropyl, cyclohexyl, adamantyl groups). These parameter changes reduce the compound's volatility, thereby minimizing unpleasant odors while maintaining the aromatic structure necessary for TYR inhibition
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds effectively inhibit tyrosinase activity, leading to superior skin-whitening effects with improved solubility and reduced side effects compared to existing treatments.
Implementation Method 1
The compounds effectively inhibit tyrosinase activity, leading to superior skin-whitening effects
Data Source
AI summary
The present disclosure relates to the technical field of chemical synthesis, and particularly relates to an α-ketoamide or substituted oxamide ester compound and a composition including the same. The α-ketoamide or substituted oxamide ester compound has a general structural formula shown in formula I: where R1 is C1-C6 alkyl or cycloalkyl, or OR2, where R2 is C1-C8 alkyl or cycloalkyl, or NR3R4, where R3 and R4 are each independently C1-C6 alkyl or cycloalkyl; or is an amine group with the following structure: where X and Y are each independently C1-C5 methylene and Z is one of CH2, O, S, and NH. The α-ketoamide or substituted oxamide ester compound of the present disclosure can effectively inhibit tyrosinase (TYR) activity to suppress melanin synthesis, and exhibits an excellent skin-whitening effect. Compared with the prior art, the molecular spatial structure of the α-ketoamide or substituted oxamide ester compound in the present disclosure is significantly altered, and possesses increased interaction sites with TYR and improved solubility, resulting in superior efficacy.